IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 9 April 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.01497-06v1
75/7/3561    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Auerbuch, V.
Right arrow Articles by Isberg, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Auerbuch, V.
Right arrow Articles by Isberg, R. R.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.01497-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin 10

Victoria Auerbuch and Ralph R. Isberg*

Howard Hughes Medical Institute and Department of Molecular Biology and Microbiology, Tufts University School of Medicine, 150 Harrison Avenue, Boston, MA 02111

* To whom correspondence should be addressed. Email: ralph.isberg{at}tufts.edu.


   Abstract

Pathogenic Yersinia translocate effector proteins into target cells via a type III secretion system (TTSS), modulating the host immune response. A component of the TTSS translocon, LcrV, has been implicated in preventing inflammation through Toll-like receptor-2 (TLR2) by inducing expression of the anti-inflammatory cytokine interleukin-10 (IL-10). TLR2-/- mice were reported to be less susceptible to the enteropathogen Y. enterocolitica. To determine whether TLR2 also plays a role in recognition of the enteropathogen Y. pseudotuberculosis and whether this results in an immune response that is detrimental to the host, we evaluated the macrophage cytokine response to live Y. pseudotuberculosis and analyzed the susceptibility of TLR2-/- mice to enteropathogenic Yersinia. We find that Yersinia induction of macrophage IL-10 occurs independently of TLR2 and LcrV and is blocked by the TTSS. In particular, the TTSS effector protein YopJ, which inhibits production of the inflammatory cytokine tumor necrosis factor-a (TNF-a), also inhibits IL-10 expression. Consistent with these results, IL-10 is undetectable in Y. pseudotuberculosis-infected mouse tissues until advanced stages of infection. In addition, we find that TLR2-/- mice (derived independently from those used in previous reports) do not display altered susceptibility to enteropathogenic Yersinia compared to wildtype mice. Tissue levels of IL-10, as well as the inflammatory cytokines TNF-a, IL-6, and interferon-g and the chemokine macrophage chemotactic protein-1 are similar between TLR2+/+ and TLR2-/- mice during enteropathogenic Yersinia infection. Therefore, the absence of TLR2 alone does not affect the cytokine response of macrophages to, nor the in vivo growth and survival of, enteropathogenic Yersinia.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.